Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic Radiosurgery

NCT04689048 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT04689048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04689048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic Radiosurgery
Lead sponsor
Baptist Health South Florida
Phase
Phase 1
Overall status
Recruiting
Start date
April 4, 2022
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain metastases, brain metastases, adult